vs
LEE ENTERPRISES, Inc（LEE）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
LEE ENTERPRISES, Inc的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.7倍（$130.1M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -10.0%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $3.7M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -5.8%）
李企业是一家上市美国传媒企业，在全美25个州运营着72份日报，同时还经营超过350份周报、分类广告刊物及各类专业刊物。公司由阿尔弗雷德·威尔逊·李于1890年创立，总部坐落于爱荷华州达文波特。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
LEE vs PBYI — 直观对比
营收规模更大
LEE
是对方的1.7倍
$75.5M
营收增速更快
PBYI
高出37.8%
-10.0%
自由现金流更多
PBYI
多$10.7M
$3.7M
两年增速更快
PBYI
近两年复合增速
-5.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $130.1M | $75.5M |
| 净利润 | $-5.6M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 4.0% | 22.7% |
| 净利率 | -4.3% | — |
| 营收同比 | -10.0% | 27.7% |
| 净利润同比 | 66.5% | — |
| 每股收益（稀释后） | $-0.92 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LEEPBYI
| Q4 25 | $130.1M | $75.5M | ||
| Q3 25 | $139.1M | $54.5M | ||
| Q2 25 | $141.3M | $52.4M | ||
| Q1 25 | $137.4M | $46.0M | ||
| Q4 24 | $144.6M | $59.1M | ||
| Q3 24 | $158.6M | $80.5M | ||
| Q2 24 | $150.6M | $47.1M | ||
| Q1 24 | $146.6M | $43.8M |
净利润LEEPBYI
| Q4 25 | $-5.6M | — | ||
| Q3 25 | $-6.4M | $8.8M | ||
| Q2 25 | $-1.9M | $5.9M | ||
| Q1 25 | $-12.5M | $3.0M | ||
| Q4 24 | $-16.7M | — | ||
| Q3 24 | $-10.1M | $20.3M | ||
| Q2 24 | $-4.3M | $-4.5M | ||
| Q1 24 | $-12.2M | $-4.8M |
毛利率LEEPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率LEEPBYI
| Q4 25 | 4.0% | 22.7% | ||
| Q3 25 | -1.0% | 17.6% | ||
| Q2 25 | 3.3% | 12.7% | ||
| Q1 25 | -3.3% | 8.7% | ||
| Q4 24 | -2.3% | 22.6% | ||
| Q3 24 | -2.3% | 27.4% | ||
| Q2 24 | 3.3% | -4.6% | ||
| Q1 24 | -3.1% | -5.3% |
净利率LEEPBYI
| Q4 25 | -4.3% | — | ||
| Q3 25 | -4.6% | 16.2% | ||
| Q2 25 | -1.4% | 11.2% | ||
| Q1 25 | -9.1% | 6.5% | ||
| Q4 24 | -11.6% | — | ||
| Q3 24 | -6.4% | 25.2% | ||
| Q2 24 | -2.8% | -9.6% | ||
| Q1 24 | -8.3% | -11.0% |
每股收益（稀释后）LEEPBYI
| Q4 25 | $-0.92 | $0.26 | ||
| Q3 25 | $-1.02 | $0.17 | ||
| Q2 25 | $-0.31 | $0.12 | ||
| Q1 25 | $-2.07 | $0.06 | ||
| Q4 24 | $-2.80 | $0.40 | ||
| Q3 24 | $-1.68 | $0.41 | ||
| Q2 24 | $-0.73 | $-0.09 | ||
| Q1 24 | $-2.06 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $-48.7M | $130.3M |
| 总资产 | $592.6M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LEEPBYI
| Q4 25 | $12.6M | $97.5M | ||
| Q3 25 | $10.0M | $94.4M | ||
| Q2 25 | $14.1M | $96.0M | ||
| Q1 25 | $4.7M | $93.2M | ||
| Q4 24 | $6.1M | $101.0M | ||
| Q3 24 | $9.6M | $96.7M | ||
| Q2 24 | $13.4M | $96.8M | ||
| Q1 24 | $16.1M | $107.2M |
总债务LEEPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益LEEPBYI
| Q4 25 | $-48.7M | $130.3M | ||
| Q3 25 | $-43.3M | $115.3M | ||
| Q2 25 | $-40.5M | $104.7M | ||
| Q1 25 | $-38.9M | $97.1M | ||
| Q4 24 | $-26.7M | $92.1M | ||
| Q3 24 | $-9.9M | $71.1M | ||
| Q2 24 | $4.0M | $48.5M | ||
| Q1 24 | $7.9M | $51.0M |
总资产LEEPBYI
| Q4 25 | $592.6M | $216.3M | ||
| Q3 25 | $601.7M | $202.9M | ||
| Q2 25 | $622.7M | $194.9M | ||
| Q1 25 | $623.9M | $196.2M | ||
| Q4 24 | $633.0M | $213.3M | ||
| Q3 24 | $649.2M | $220.7M | ||
| Q2 24 | $677.5M | $205.0M | ||
| Q1 24 | $684.8M | $214.1M |
负债/权益比LEEPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $3.7M | $14.4M |
| 自由现金流率自由现金流/营收 | 2.9% | 19.1% |
| 资本支出强度资本支出/营收 | 0.6% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $1.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流LEEPBYI
| Q4 25 | $4.5M | $14.4M | ||
| Q3 25 | $-6.3M | $9.7M | ||
| Q2 25 | $8.9M | $14.1M | ||
| Q1 25 | $-790.0K | $3.6M | ||
| Q4 24 | $-7.3M | $15.6M | ||
| Q3 24 | $-261.0K | $11.0M | ||
| Q2 24 | $-1.9M | $1.0M | ||
| Q1 24 | $3.2M | $11.2M |
自由现金流LEEPBYI
| Q4 25 | $3.7M | $14.4M | ||
| Q3 25 | $-8.3M | $9.7M | ||
| Q2 25 | $8.3M | $14.1M | ||
| Q1 25 | $-2.2M | $3.6M | ||
| Q4 24 | $-8.9M | $15.6M | ||
| Q3 24 | $-2.9M | $11.0M | ||
| Q2 24 | $-5.5M | $1.0M | ||
| Q1 24 | $1.3M | — |
自由现金流率LEEPBYI
| Q4 25 | 2.9% | 19.1% | ||
| Q3 25 | -6.0% | 17.7% | ||
| Q2 25 | 5.9% | 26.8% | ||
| Q1 25 | -1.6% | 7.7% | ||
| Q4 24 | -6.1% | 26.4% | ||
| Q3 24 | -1.8% | 13.7% | ||
| Q2 24 | -3.6% | 2.1% | ||
| Q1 24 | 0.9% | — |
资本支出强度LEEPBYI
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 1.4% | 0.0% | ||
| Q2 25 | 0.4% | 0.0% | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 1.1% | 0.0% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 2.4% | 0.0% | ||
| Q1 24 | 1.3% | 0.0% |
现金转化率LEEPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LEE
| Advertising And Marketing Services | $60.0M | 46% |
| Subscription And Circulation | $57.7M | 44% |
| Other | $12.4M | 10% |
PBYI
暂无分部数据
